Novartis has filed a lawsuit seeking to block a Maryland law that requires the company to ship its medicines to any pharmacy working with hospitals
Ultragenyx said Thursday afternoon that its gene therapy for a rare liver ailment, glycogen disease type 1A, succeeded in a Phase 3 trial, setting up
Three United Nations agencies today issued a stark warning that all indications point to a significant deterioration of the nutrition situation for children and mothers
A drug approved to treat certain autoimmune diseases and cancers successfully alleviated symptoms of a rare genetic syndrome called autoimmune polyendocrine syndrome type 1 (APS-1).
Sanofi made the $1.7bn purchase of Inhibrx in January 2024. Credits: JHVEPhoto/Shutterstock.com After declaring its intention to purchase Inhibrx for $1.7bn in January, Sanofi has
A new study from the UC Davis School of Medicine found striking differences at the cellular level between male and female mice with heart failure
A new study to be presented at the SLEEP 2024 annual meeting found that better sleep health was associated with lower levels of loneliness, and
A new study to be presented at the SLEEP 2024 annual meeting found a distinct relationship between sleep duration, social media usage, and brain activation
Caption: Royalty Pharma projects more than $1bn in annual peak sales for vorasidenib. Image credit: Shutterstock/ ADragan. As Servier’s day of reckoning with US Food